Trial Profile
Safety and Efficacy of EXE844 Otic Suspension in the Treatment of Otitis Media at Time of Tympanostomy Tube Insertion
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Finafloxacin (Primary)
- Indications Otitis media
- Focus Registrational; Therapeutic Use
- Sponsors Alcon
- 27 Jun 2016 Status changed from active, no longer recruiting to completed.
- 19 May 2016 Status changed from recruiting to active, no longer recruiting.
- 26 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.